Peter Bains, Group CEO of Biocon, discusses his outlook and strategy for business growth after the company’s latest earnings, and says preparations for GLP drugs for diabetes and obesity drugs, are underway and will help boost sales. He speaks with Shery Ahn and Haidi Stroud-Watts on “Bloomberg: The Asia Trade”. (Source: Bloomberg)Read More
